Blood thinners after stroke in cancer patients
Part of Brain & nervous system, Cancer, Heart & circulation clinical trials.
This study compares different blood-thinning medicines to see which works better for people who have had a stroke linked to cancer. If you have had a stroke and have a history of cancer, joining could help doctors learn the best way to prevent another stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had an ischemic stroke (a stroke caused by a blocked blood vessel) confirmed by a doctor and brain scan.
- You joined this study within 7 days of your stroke symptoms starting.
- You have a history of cancer, whether it is active or in the past.
- You can give written permission to be in the study, or have a family member or legal guardian do it for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study tests whether taking a blood thinner after a stroke is safe and helpful for people who have atrial fibrillation (an irregular heartbeat) and have had a bleeding stroke in the past. It aims to prevent future strokes while managing the risk of another brain bleed.
This trial tests whether a clot-busting drug given through a vein can safely and effectively treat strokes in people who also have active cancer. It aims to see if this treatment can improve recovery without increasing bleeding risks.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.